Droopy eyelid surgery may boost vision and confidence, new study hopes to prove
NCT ID NCT07534436
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 73 people with congenital ptosis (droopy eyelids) who are already scheduled for a specific surgery. Researchers will check their vision and ask about their quality of life before surgery and at 1, 3, and 6 months after. The goal is to see if the surgery improves eyesight and emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Levator Resection combined with Fascial Sheath Suspension surgery
- What this could lead to
- If successful, this study could show that this combined surgery improves vision and quality of life for people with congenital ptosis.
- What could go wrong
- This is a small observational study (73 people) with no control group, so results may not apply to everyone. It only tracks outcomes for 6 months, so long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL PTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Ophthalmic Center
RECRUITINGGuangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.